April

April 18, 2014

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor p53 homologue TAp63 via down regualtion of its target gene, 18/April/2014, 22.32

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor p53 […]
April 18, 2014

Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor GRHL3 via down regulation of its target gene, 18/April/2014, 22.28

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression […]
April 18, 2014

Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of SOD3 via down regulation of its target gene, 18/April/2014, 22.25

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression […]
April 18, 2014

Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor Big-h3 via down regulation of its target gene, 18/April/2014, 22.23

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression […]